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tTATE-OF-THE-ART PAPER639Cardiorenal Anemiamir Kazory, Edward A. Ross
ardiorenal anemia syndrome refers to the simultaneous presence of anemia, heart failure
HF), and chronic kidney disease. The reciprocal relationships between these 3 conditions
ave been studied with inconsistent and sometimes paradoxical results. In this paper, Kazory
nd Ross review the pathophysiological concepts underlying the complicated interactions
etween these 3 conditions. They conclude by suggesting a pragmatic approach to the care of
F patients with anemia, with treatment goals that are dynamic and disease-specific, rather
han based on a simplistic, hemoglobin-specific approach.CLINICAL RESEARCH NTERVENTIONAL CARDIOLOGY648Bivalirudin and Clopidogrel With and Without Eptifibatide for Elective Stenting0
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*aul A. Gurbel, Kevin P. Bliden, Jorge F. Saucedo, Thomas A. Suarez, Joseph DiChiara, Mark J. Antonino,
lisabeth Mahla, Anand Singla, William R. Herzog, Ashwani K. Bassi, Thomas A. Hennebry,
ania B. Gesheff, Udaya S. Tantry
igh post-percutaneous coronary intervention (PCI) platelet reactivity (PR) has been
orrelated with clinical events, including periprocedural myocardial infarction (MI) and stent
hrombosis. The CLEAR PLATELETS-2 (Clopidogrel With Eptifibatide to Arrest the
eactivity of Platelets) study compared the effect of bivalirudin monotherapy versus
ivalirudin plus eptifibatide on PR and thrombin-induced platelet-fibrin clot strength (TIP-
CS) in stable PCI patients. Sixty percent of subjects were loaded with 600 mg clopidogrel
mmediately post-stenting; the other 40% were already on clopidogrel. PR, TIP-FCS, and
yonecrosis markers were serially determined. The addition of eptifibatide markedly lowered
R and reduced mean TIP-FCS, regardless of clopidogrel dosing. Patients who developed
eriprocedural infarction had higher mean 18-h PR and TIP-FCS. In elective PCI patients,
he combination of eptifibatide and bivalirudin may reduce the risk of periprocedural MI.(continued on page A-22)
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fNTERVENTIONAL CARDIOLOGY658Increased Risk of Stent Thrombosis With PES Compared With BMS or SESEditorial Comment
Christodoulos Stefanadis andnne Kaltoft, Lisette Okkels Jensen, Michael Maeng, Hans Henrik Tilsted, Per Thayssen, Morten Bøttcher,
ens Flensted Lassen, Lars Romer Krusell, Klaus Rasmussen, Knud Nørregaard Hansen, Lars Pedersen,
øren Paaske Johnsen, Henrik Toft Sørensen, Leif Thuesen
altoft and colleagues studied the rates of stent thrombosis (ST) with an extended follow-up
eriod of 2 years in a registry of 12,000 patients. The data are reported separately for patients
reated with sirolimus-eluting stents (SES), paclitaxel-eluting stents (PES), or bare-metal
tents (BMS). The decision for BMS, SES, or PES was at operator discretion. There was no
ignificant difference in the rates of definite ST between SES and BMS, but the rate was 1.8
imes higher in the PES group. The rates of myocardial infarction (MI) and 12- to 24-
onth mortality were also higher in the PES group. These results suggest that patients
reated with PES have an increased risk of ST and MI compared with those treated with
MS and SES.NTIPLATELET THERAPY667Differences Between Platelet Cox Inhibition and Platelet Function AssaysEditorial Commentrancesca Santilli, Bianca Rocca, Raimondo De Cristofaro, Stefano Lattanzio, Laura Pietrangelo,
ida Habib, Caterina Pettinella, Antonio Recchiuti, Elisabetta Ferrante, Giovanni Ciabattoni,
iovanni Davì, Carlo Patrono
antilli and colleagues compared serum thromboxane (TX) levels, which are lowered with
ow-dose aspirin, with biochemical and functional measures of the antiplatelet efficacy of
spirin. The intersubject and intrasubject variability as well as variations over time were also
ssessed. Serum TXB2 was reduced by 99% in all subjects. Adenosine diphosphate- and
ollagen-induced aggregation were highly variable and poorly correlated with recent aspirin
sage. With any of the functional assays, occasionally “resistant” subjects were found to be
responders” at other time points. Platelet cyclooxygenase-1 activity, as reflected by serum
XB2 levels, is uniformly and persistently suppressed by low-dose aspirin; functional assays of
latelet inhibition have poor reducibility.ARDIOMYOPATHY681Electroanatomic Mapping to Guide Endomyocardial Biopsy for Suspected ARVCaurizio Pieroni, Antonio Dello Russo, Francesca Marzo, Gemma Pelargonio, Michela Casella,
ulvio Bellocci, Filippo Crea
he diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC) remains difficult.
ndomyocardial biopsy (EMB) has low yield, presumably due to the patchy involvement of
he right ventricle. Pieroni and colleagues hypothesized that electroanatomic mapping (EAM)
ould be used to identify areas that should be targeted for biopsy. Thirty patients with a
resumed diagnosis of ARVC were studied. The diagnosis was histologically confirmed in
nly 50% of the patients; the other 50% had myocarditis. Patients with ARVC were not
istinguishable on the basis of clinical features, presence or severity of right ventricular
bnormalities, or EAM findings. EAM guidance can increase the diagnostic yield of EMB
or the diagnosis of ARVC.(continued on page A-23)
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iEART RHYTHM DISORDERS IN CHILDREN690Pediatric Junctional Ectopic Tachycardiaathryn K. Collins, George F. Van Hare, Naomi J. Kertesz, Ian H. Law, Yaniv Bar-Cohen,
nne M. Dubin, Susan P. Etheridge, Charles I. Berul, Jennifer N. Avari, Volkan Tuzcu,
arayanswami Sreeram, Michael S. Schaffer, Anne Fournier, Shubhayan Sanatani, Christopher S. Snyder,
ichard T. Smith, Jr, Luis Arabia, Robert Hamilton, Terrence Chun, Leonardo Liberman,
ahram Kakavand, Thomas Paul, Ronn E. Tanel
unctional ectopic tachycardia (JET) is a rare arrhythmia that can present at any age. Collins
nd colleagues provide an international, multicenter, retrospective study of 99 pediatric
atients with JET who had no previous history of cardiac surgery. JET was defined as a
achycardia originating from the atrioventricular junction with gradual onset, gradual
ffset, and rate variability, with a rate 95th percentile of heart rate for age. Patients
resenting at age 6 months were more likely to have incessant JET and had faster JET
ates. Amiodarone was the most commonly reported effective agent. Ablation of JET was
onducted in 46%, with approximately 85% success. There were 4 deaths (4%), all in
atients presenting at age 6 months. Patients with nonpost-operative JET have a wide
ange of clinical presentations, but most can be treated with a variety of medical, ablative,
nd device therapies.ARDIAC IMAGING
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Editorial Comment
Theodore P. Abraham andatsuhisa Ishii, Makoto Imai, Tamaki Suyama, Motoyoshi Maenaka, Takahiro Nagai, Masaki Kawanami,
utaka Seino
shii and colleagues used speckle tracking strain imaging (SI) to measure regional transverse
train before and after exercise in subjects with angina who also underwent angiography.
he end-systolic value of strain (A) and the strain after the first one-third of diastole (B)
ere measured and a strain imaging diastolic index (SI-DI) calculated as: (A  B)/A 
00%. This value was then compared to the SI-DI prior to exercise for the 3 coronary
erfusion territories. The mean SI-DI decreased from 78% to 28% after exercise in territories
erfused by an artery with a significant stenosis, but was unchanged in territories without
tenoses. SI-DI may facilitate the adoption of quantitative parameters to detect ischemia and
mprove the sensitivity of echocardiographic treadmill testing.(continued on page A-24)
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709denosine Prevents Reperfusion Energy:
More Effective, Better Tolerated When Encapsulated in LiposomesSaline Liposomes
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Editorial Comment
Michael V. Cohen andiroyuki Takahama, Tetsuo Minamino, Hiroshi Asanuma, Masashi Fujita, Tomohiro Asai,
asakatsu Wakeno, Hideyuki Sasaki, Hiroshi Kikuchi, Kouichi Hashimoto, Naoto Oku, Masanori Asakura,
iyoong Kim, Seiji Takashima, Kazuo Komamura, Masaru Sugimachi, Naoki Mochizuki, Masafumi Kitakaze
anoparticles, such as liposomes, may be a promising drug delivery system for targeting
amaged myocardium because cellular permeability is enhanced and endothelial integrity is
isrupted in areas of ischemia. Adenosine may reduce reperfusion injury, but its use
s limited by systemic vasodilation and bradycardia. Takahama and colleagues studied
EGylated liposomal adenosine in a rat model of ischemia/reperfusion. Electron
icroscopy and bioluminescence imaging showed the specific accumulation of liposomes
n ischemic/reperfused myocardium. PEGylated liposomal adenosine had a weaker effect
n blood pressure and heart rate than free adenosine and significantly reduced myocardial
nfarction size. PEGylated liposomes may augment the cardioprotective effects of
denosine while reducing the unfavorable hemodynamic effects.
